Literature DB >> 16648952

Effect of fluoroquinolones on plasma glucose levels in fasted and glucose-loaded mice.

Seiji Hori1, Junko Kizu, Masahiro Kawamura.   

Abstract

In fasted mice, plasma glucose levels were reduced by intraperitoneal administration of enoxacin, lomefloxacin, or gatifloxacin (50 mg/kg). A lower dose of these fluoroquinolones (5 mg/kg) also reduced the plasma glucose (PG) levels in glucose-loaded mice. Ciprofloxacin and levofloxacin did not reduce these levels in either fasted or glucose-loaded mice. These results suggest that each fluoroquinolone has an individual hypoglycemic action, and fluoroquinolone administration after meals might reduce PG levels at lower doses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648952     DOI: 10.1007/s10156-006-0429-z

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  6 in total

Review 1.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

2.  An evaluation of the effects of gatifloxacin on glucose homeostasis.

Authors:  Ahunna J Onyenwenyi; Almut G Winterstein; Randy C Hatton
Journal:  Pharm World Sci       Date:  2008-02-23

Review 3.  Dysglycaemias and fluoroquinolones.

Authors:  Roshan J Lewis; John F Mohr
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome.

Authors:  P Artur Plett; Carol H Sampson; Hui Lin Chua; Mandar Joshi; Catherine Booth; Alec Gough; Cynthia S Johnson; Barry P Katz; Ann M Farese; Jeffrey Parker; Thomas J MacVittie; Christie M Orschell
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

5.  Enoxacin extends lifespan of C. elegans by inhibiting miR-34-5p and promoting mitohormesis.

Authors:  Silas Pinto; Vitor N Sato; Evandro A De-Souza; Rafael C Ferraz; Henrique Camara; Ana Paula F Pinca; Diego R Mazzotti; Michael T Lovci; Guilherme Tonon; Camila M Lopes-Ramos; Raphael B Parmigiani; Martin Wurtele; Katlin B Massirer; Marcelo A Mori
Journal:  Redox Biol       Date:  2018-06-19       Impact factor: 11.799

6.  Enoxacin induces oxidative metabolism and mitigates obesity by regulating adipose tissue miRNA expression.

Authors:  Andréa Livia Rocha; Tanes Imamura de Lima; Gerson Profeta de Souza; Renan Oliveira Corrêa; Danilo Lopes Ferrucci; Bruno Rodrigues; Camila Lopes-Ramos; Daniel Nilsson; Thiago Leite Knittel; Pollyana Ribeiro Castro; Mariane Font Fernandes; Flaviano Dos Santos Martins; Raphael Bessa Parmigiani; Leonardo Reis Silveira; Hernandes F Carvalho; Johan Auwerx; Marco Aurélio R Vinolo; Jeremie Boucher; Marcelo A Mori
Journal:  Sci Adv       Date:  2020-12-02       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.